Deutsche Bank’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,762,802
| Closed | -$23.1M | – | 3626 |
|
|
2025
Q4 | $23.1M | Buy |
1,762,802
+1,729,463
| +5,188% | +$20.7M | 0.01% | 834 |
|
|
2025
Q3 | $243K | Buy |
33,339
+7,113
| +27% | +$48.1K | ﹤0.01% | 2956 |
|
|
2025
Q2 | $141K | Sell |
26,226
-9,107
| -26% | -$44.1K | ﹤0.01% | 3119 |
|
|
2025
Q1 | $189K | Sell |
35,333
-4,411
| -11% | -$30.9K | ﹤0.01% | 2975 |
|
|
2024
Q4 | $355K | Buy |
39,744
+13,986
| +54% | +$149K | ﹤0.01% | 2798 |
|
|
2024
Q3 | $284K | Buy |
25,758
+6,634
| +35% | +$73.8K | ﹤0.01% | 2746 |
|
|
2024
Q2 | $174K | Sell |
19,124
-5,092
| -21% | -$49.7K | ﹤0.01% | 2879 |
|
|
2024
Q1 | $341K | Buy |
24,216
+7,597
| +46% | +$94.6K | ﹤0.01% | 2533 |
|
|
2023
Q4 | $128K | Hold |
16,619
| – | – | ﹤0.01% | 3111 |
|
|
2023
Q3 | $124K | Buy |
16,619
+3,422
| +26% | +$29.2K | ﹤0.01% | 3058 |
|
|
2023
Q2 | $110K | Buy |
+13,197
| New | +$152K | ﹤0.01% | 3230 |
|
|
2021
Q2 | – | Sell |
-1,967
| Closed | -$34K | – | 4594 |
|
|
2021
Q1 | $34K | Sell |
1,967
-207
| -10% | -$3.74K | ﹤0.01% | 4316 |
|
|
2020
Q4 | $28K | Buy |
2,174
+646
| +42% | +$11.5K | ﹤0.01% | 4208 |
|
|
2020
Q3 | $57K | Buy |
1,528
+144
| +10% | +$5.71K | ﹤0.01% | 3820 |
|
|
2020
Q2 | $53K | Buy |
+1,384
| New | +$49.3K | ﹤0.01% | 3784 |
|
|
2020
Q1 | – | Sell |
-889
| Closed | -$31K | – | 4327 |
|
|
2019
Q4 | $31K | Buy |
+889
| New | +$28K | ﹤0.01% | 4141 |
|
|
2019
Q2 | – | Sell |
-4,484
| Closed | -$213K | – | 5278 |
|
|
2019
Q1 | $213K | Sell |
4,484
-10,463
| -70% | -$355K | ﹤0.01% | 3961 |
|
|
2018
Q4 | $391K | Buy |
14,947
+10,733
| +255% | +$406K | ﹤0.01% | 3487 |
|
|
2018
Q3 | $203K | Sell |
4,214
-3,098
| -42% | -$139K | ﹤0.01% | 4231 |
|
|
2018
Q2 | $421K | Sell |
7,312
-1,156
| -14% | -$107K | ﹤0.01% | 3931 |
|
|
2018
Q1 | $919K | Buy |
8,468
+4,713
| +126% | +$471K | ﹤0.01% | 3363 |
|
|
2017
Q4 | $335K | Buy |
+3,755
| New | +$442K | ﹤0.01% | 3797 |
|
|
2017
Q3 | – | Sell |
-93
| Closed | -$7K | – | 4867 |
|
|
2017
Q2 | $7K | Buy |
93
+90
| +3,000% | +$7.49K | ﹤0.01% | 4706 |
|
|
2017
Q1 | $0 | Buy |
+3
| New | +$413 | ﹤0.01% | 4900 |
|
|
2016
Q3 | – | Sell |
-86
| Closed | -$19K | – | 4901 |
|
|
2016
Q2 | $19K | Buy |
86
+75
| +682% | +$22.6K | ﹤0.01% | 4764 |
|
|
2016
Q1 | $3K | Sell |
11
-8
| -42% | -$2.76K | ﹤0.01% | 5009 |
|
|
2015
Q4 | $8K | Sell |
19
-7
| -27% | -$3.36K | ﹤0.01% | 4964 |
|
|
2015
Q3 | $12K | Sell |
26
-14
| -35% | -$10K | ﹤0.01% | 4906 |
|
|
2015
Q2 | $29K | Buy |
+40
| New | +$30.2K | ﹤0.01% | 4790 |
|
Deutsche Bank's ATXS Position: Q1 2026 in Review
Deutsche Bank sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 1,762,802 shares — an estimated $23.1M sold.
Deutsche Bank first reported a position in ATXS in Q2 2015 and held it in 29 quarters. The position peaked at $23.1M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Deutsche Bank reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Deutsche Bank sold 1,762,802 Astria Therapeutics shares in Q1 2026, an estimated $23.1M.
- Deutsche Bank first reported a position in Astria Therapeutics in Q2 2015 and held it in 29 quarters.
- Deutsche Bank's Astria Therapeutics position peaked at $23.1M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.